General Information of This Antibody
Antibody ID
ANI0STYHN
Antibody Name
huAD208.14.1
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG1-kappa
Antigen Name
Leucine-rich repeat-containing protein 15 (LRRC15)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
HuAD208.14.1-vcMMAE-DAR4 [Investigative]
Discovered Using Cell Line-derived Xenograft Model
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Tumor Growth Inhibition value (TGI)
90.12% (Day 21)
High LRRC15 expression (LRRC15+++; IHC 3+)
Method Description
LRRC15 expression on stromal cells asassessed by IHC in an untreated xenograft tumor of 200-800 mm in volume, representative for eachxenograft model. In vivo activity of huAD208.14.1-vcMMAE-DAR4 (3 mg/kg) was demonstrated in EBC-1 xenografts.
In Vivo Model EBC-1 CDX model
In Vitro Model Lung squamous cell carcinoma EBC-1 cells CVCL_2891
References
Ref 1 Anti-huLRRC15 antibody drug conjugates and methods for their use. 2017-06-08

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.